Cyclophosphamide Therapy in Pediatric Multiple Sclerosis

Neurology - United States
doi 10.1212/wnl.0b013e3181a8164c
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis

JAMA Neurology
Neurology
2013English

Pediatric Multiple Sclerosis

Neurology
Neurology
2016English

Pediatric Multiple Sclerosis

2016English

Longitudinal Evaluation of Cognitive Functioning in Pediatric Multiple Sclerosis: Report From the US Pediatric Multiple Sclerosis Network

Multiple Sclerosis
Neurology
2014English

Symptomatic Therapy in Multiple Sclerosis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2011English

Menarche Increases Relapse Risk in Pediatric Multiple Sclerosis

Multiple Sclerosis
Neurology
2015English

Pediatric Multiple Sclerosis in Portugal: A Multicentre Study

Acta Medica Portuguesa
Medicine
2016English

Environmental Risk Factors for Pediatric Multiple Sclerosis

US Neurology
NeuroscienceNeurology
2010English

Clinical Trials in Pediatric Multiple Sclerosis: Pending Landscape and Challenges

Brain Disorders & Therapy
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy